Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A B1a–natural IgG–neutrophil axis is impaired in viral- and steroid-associated aspergillosis
Nicole Sarden, Sarthak Sinha, Kyle Potts, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 674
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease
Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 27
Biofilm exopolysaccharides alter sensory-neuron-mediated sickness during lung infection
Elise Granton, Luke Brown, Manon Defaye, et al.
Cell (2024) Vol. 187, Iss. 8, pp. 1874-1888.e14
Closed Access | Times Cited: 18
Treatment of Invasive Aspergillosis: How It’s Going, Where It’s Heading
Johannes Boyer, Simon Feys, Isabella Zsifkovits, et al.
Mycopathologia (2023) Vol. 188, Iss. 5, pp. 667-681
Open Access | Times Cited: 29
High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation
Simon Feys, Katrien Lagrou, Hanne Moon Lauwers, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 2, pp. 361-370
Open Access | Times Cited: 23
Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients
Simon Feys, Agostinho Carvalho, Cornelius J. Clancy, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 9, pp. 728-742
Closed Access | Times Cited: 12
Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study
Simon Feys, Sam Vanmassenhove, Sirima Kraisin, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 3, pp. e247-e260
Open Access | Times Cited: 9
Integrating genetic and immune factors to uncover pathogenetic mechanisms of viral-associated pulmonary aspergillosis
Samuel M. Gonçalves, Inês M. Pereira, Simon Feys, et al.
mBio (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 5
Cell-cell crosstalk in the pathogenesis of acute lung injury and acute respiratory distress syndrome
Zhenzhen Zhu, Ying Zhang, Huan Chen, et al.
Tissue Barriers (2025)
Closed Access
Viral reactivations and fungal infections in nonresolving acute respiratory distress syndrome
Lenn Maessen, Leonoor S. Boers, Jannes Heylen, et al.
European Respiratory Review (2025) Vol. 34, Iss. 175, pp. 240153-240153
Open Access
Role of the microbiota-gut-brain axis in postacute COVID syndrome
Mélanie G. Gareau, Kim E. Barrett
AJP Gastrointestinal and Liver Physiology (2023) Vol. 324, Iss. 4, pp. G322-G328
Open Access | Times Cited: 13
COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis
Jonas Frost, Maximilian Gornicec, Alexander C. Reisinger, et al.
Mycopathologia (2024) Vol. 189, Iss. 1
Open Access | Times Cited: 4
Coinfections in the lung: How viral infection creates a favorable environment for bacterial and fungal infections
Joshua J. Obar, Kelly M. Shepardson
PLoS Pathogens (2023) Vol. 19, Iss. 5, pp. e1011334-e1011334
Open Access | Times Cited: 10
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity
Itai Doron, Takato Kusakabe, Iliyan D. Iliev
Seminars in Immunology (2023) Vol. 67, pp. 101757-101757
Open Access | Times Cited: 8
Humoral Immunity Against Aspergillus fumigatus
Sarah Dellière, Vishukumar Aimanianda
Mycopathologia (2023) Vol. 188, Iss. 5, pp. 603-621
Open Access | Times Cited: 8
Damping excessive viral-induced IFN-γ rescues the impaired anti-Aspergillus host immune response in influenza-associated pulmonary aspergillosis
Laura Seldeslachts, Frederik Staels, Marina E. Gkountzinopoulou, et al.
EBioMedicine (2024) Vol. 108, pp. 105347-105347
Open Access | Times Cited: 2
Dysregulated pulmonary inflammatory responses exacerbate the outcome of secondary aspergillosis following influenza
Chrono K. Lee, Lorena V. N. Oliveira, Ali Akalin, et al.
mBio (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 7
Natural antibodies to polysaccharide capsules enable Kupffer cells to capture invading bacteria in the liver sinusoids
Xianbin Tian, Yanni Liu, Kun Yan Zhu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Study Protocol: A randomized, double-blind, placebo-controlled trial of isavuconazole prophylaxis for the prevention of COVID-19-associated pulmonary aspergillosis
Jeffrey D. Jenks, Martin Hoenigl, George R. Thompson
Contemporary Clinical Trials Communications (2024) Vol. 39, pp. 101310-101310
Open Access | Times Cited: 2
How to lose resistance to Aspergillus infections
Jean‐Pierre Gangneux, Martin Hoenigl, Nicolas Papon
Trends in Microbiology (2023) Vol. 31, Iss. 3, pp. 222-224
Open Access | Times Cited: 5
Alligamycin A, an unprecedented antifungal β-lactone spiroketal macrolide fromStreptomyces iranensis
Zhijie Yang, Yi‐Jun Qiao, Emil Strøbech, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Assessing the entire landscape of antifungal immune response to COVID-19-associated pulmonary aspergillosis
Florian Reizine, Jean‐Marc Tadié, Murielle Grégoire, et al.
The Lancet Microbe (2024), pp. 100861-100861
Open Access
Humoral pathways of innate immune regulation in granuloma formation
Diana Santos‐Ribeiro, Cristina Cunha, Agostinho Carvalho
Trends in Immunology (2024) Vol. 45, Iss. 6, pp. 419-427
Closed Access
Alligamycin A, an antifungal β-lactone spiroketal macrolide from Streptomyces iranensis
Zhijie Yang, Yi‐Jun Qiao, Emil Strøbech, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Case Report and Literature Review of “Treatment Failure” of Aspergillus Infection Secondary to Influenza a Virus
Peikun Teng, Yuzhan Liu, Xingyu Zhang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 10305-10311
Open Access
Two-transcript signature for differentiation and clinical outcomes in severe fever with thrombocytopenia syndrome (SFTS) patients: a double-blind, multicenter, validation study
Nannan Xu, Sai Wen, Yongyuan Yao, et al.
Journal of Clinical Microbiology (2024) Vol. 63, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top